Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstanze Miehle

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical Endocrinology|September 29, 2011
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsiaKonstanze Miehle, Holger Stepan, Mathias Fasshauer
Endocrine|October 11, 2017
Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophyKonstanze Miehle, Michael Stumvoll, Mathias Fasshauer, et al.
Biomolecules|November 27, 2024
Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy SyndromesMichelle Krienke, Susan Kralisch, Leonie Wagner, et al.
Obesity Facts|March 8, 2013
Insulin administration acutely decreases vaspin serum concentrations in humansPeter Kovacs, Konstanze Miehle, Benjamin Sandner, et al.
Journal of the Endocrine Society|July 5, 2023
Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With LipodystrophyHaiko Schlögl, Arno Villringer, Konstanze Miehle, et al.
Cytokine|December 13, 2018
Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatmentJanett Püschel, Konstanze Miehle, Karsten Müller, et al.
Journal of the Endocrine Society|May 14, 2023
Reward Processing During Monetary Incentive Delay Task After Leptin Substitution in Lipodystrophy-an fMRI Case SeriesHaiko Schlögl, Lieneke Janssen, Mathias Fasshauer, et al.
JCEM Case Reports|November 12, 2025
Coincidence of Autoimmune Diabetes Mellitus and Familial Partial LipodystrophyMichelle Krienke, Hartmut H J Schmidt, Janine Buettner, et al.
Clinical Endocrinology|June 30, 2015
Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3Konstanze Miehle, Joseph Porrmann, Diana Mitter, et al.
Obesity Facts|August 29, 2022
Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with LipodystrophyDiana Branco Vieira, Jochen Antel, Triinu Peters, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical Endocrinology|September 29, 2011
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsiaKonstanze Miehle, Holger Stepan, Mathias Fasshauer
Endocrine|October 11, 2017
Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophyKonstanze Miehle, Michael Stumvoll, Mathias Fasshauer, et al.
Biomolecules|November 27, 2024
Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy SyndromesMichelle Krienke, Susan Kralisch, Leonie Wagner, et al.
Obesity Facts|March 8, 2013
Insulin administration acutely decreases vaspin serum concentrations in humansPeter Kovacs, Konstanze Miehle, Benjamin Sandner, et al.
Journal of the Endocrine Society|July 5, 2023
Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With LipodystrophyHaiko Schlögl, Arno Villringer, Konstanze Miehle, et al.
Cytokine|December 13, 2018
Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatmentJanett Püschel, Konstanze Miehle, Karsten Müller, et al.
Journal of the Endocrine Society|May 14, 2023
Reward Processing During Monetary Incentive Delay Task After Leptin Substitution in Lipodystrophy-an fMRI Case SeriesHaiko Schlögl, Lieneke Janssen, Mathias Fasshauer, et al.
JCEM Case Reports|November 12, 2025
Coincidence of Autoimmune Diabetes Mellitus and Familial Partial LipodystrophyMichelle Krienke, Hartmut H J Schmidt, Janine Buettner, et al.
Clinical Endocrinology|June 30, 2015
Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3Konstanze Miehle, Joseph Porrmann, Diana Mitter, et al.
Obesity Facts|August 29, 2022
Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with LipodystrophyDiana Branco Vieira, Jochen Antel, Triinu Peters, et al.
Pageof 4